ARHGEF19 and non-small cell lung carcinoma: The downregulated levels of Ephexin2 by miR-503 have an inhibitory effect on cancer metastasis in hepatocellular carcinoma model and miR-29b, which downregulates the levels of Ephexin2, is decreased in non-small cell lung cancer (NSCLC) [39,40].